Search

Author/Creator Voccia, Isabelle

1. Nintedanib plus pemetrexed versus placebo plus pemetrexed in patients with relapsed or refractory, advanced non-small cell lung cancer (LUME-Lung 2): A randomized, double-blind, phase III trial. (December 2016)

Authors:
Hanna, Nasser H.; Kaiser, Rolf; Sullivan, Richard N.; Aren, Osvaldo Rudy; Ahn, Myung-Ju; Tiangco, Beatrice; Voccia, Isabelle; Pawel, Joachim von; Kovcin, Vladimir; Agulnik, Jason; Gaschler-Markefski, Birgit; Barrueco, José; Sikken, Patricia; Schloss, Charles; Kim, Joo-Hang
Journal:
Lung cancer
Issue:
Volume 102(2016)
Page Start:
65
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Phase II study of afatinib plus pembrolizumab in patients with squamous cell carcinoma of the lung following progression during or after first-line chemotherapy (LUX-Lung-IO). (April 2022)

Authors:
Levy, Benjamin; Barlesi, Fabrice; Paz-Ares, Luis; Bennouna, Jaafar; Erman, Mustafa; Felip, Enriqueta; Isla, Dolores; Ryun Kim, Hye; Kim, Sang-We; Madelaine, Jeannick; Molinier, Olivier; Özgüroğlu, Mustafa; Rodríguez Abreu, Delvys; Adeniji, Abidemi; Lorence, Robert M.; Voccia, Isabelle; Chisamore,...
Journal:
Lung cancer
Issue:
Volume 166(2022)
Page Start:
107
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search